Cargando…
Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination
Guillain-Barré syndrome (GBS) has occasionally occurred in people who have received coronavirus disease 2019 (COVID-19) vaccines. Dysgeusia is rare symptom of GBS. We herein report a rare case of sensory ataxic GBS with dysgeusia just after the second dose of the Pfizer-BioNTech COVID-19 vaccine. Al...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259306/ https://www.ncbi.nlm.nih.gov/pubmed/35342134 http://dx.doi.org/10.2169/internalmedicine.8967-21 |
| _version_ | 1784741748536246272 |
|---|---|
| author | Ogata, Shunsuke Ishii, Yoshito Asano, Keiichiro Kobayashi, Erena Kubota, Shun Takahashi, Keita Miyaji, Yosuke Higashiyama, Yuichi Joki, Hideto Doi, Hiroshi Koga, Michiaki Takeuchi, Hideyuki Tanaka, Fumiaki |
| author_facet | Ogata, Shunsuke Ishii, Yoshito Asano, Keiichiro Kobayashi, Erena Kubota, Shun Takahashi, Keita Miyaji, Yosuke Higashiyama, Yuichi Joki, Hideto Doi, Hiroshi Koga, Michiaki Takeuchi, Hideyuki Tanaka, Fumiaki |
| author_sort | Ogata, Shunsuke |
| collection | PubMed |
| description | Guillain-Barré syndrome (GBS) has occasionally occurred in people who have received coronavirus disease 2019 (COVID-19) vaccines. Dysgeusia is rare symptom of GBS. We herein report a rare case of sensory ataxic GBS with dysgeusia just after the second dose of the Pfizer-BioNTech COVID-19 vaccine. Although autoantibodies against glycolipids were not detected, immunotherapy with intravenous immunoglobulin and methylprednisolone pulse therapy effectively ameliorated the symptoms. Our report suggests that the COVID-19 vaccine may induce various clinical subtypes of GBS, including a rare variant with sensory ataxia and dysgeusia. |
| format | Online Article Text |
| id | pubmed-9259306 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Japanese Society of Internal Medicine |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92593062022-07-19 Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination Ogata, Shunsuke Ishii, Yoshito Asano, Keiichiro Kobayashi, Erena Kubota, Shun Takahashi, Keita Miyaji, Yosuke Higashiyama, Yuichi Joki, Hideto Doi, Hiroshi Koga, Michiaki Takeuchi, Hideyuki Tanaka, Fumiaki Intern Med Case Report Guillain-Barré syndrome (GBS) has occasionally occurred in people who have received coronavirus disease 2019 (COVID-19) vaccines. Dysgeusia is rare symptom of GBS. We herein report a rare case of sensory ataxic GBS with dysgeusia just after the second dose of the Pfizer-BioNTech COVID-19 vaccine. Although autoantibodies against glycolipids were not detected, immunotherapy with intravenous immunoglobulin and methylprednisolone pulse therapy effectively ameliorated the symptoms. Our report suggests that the COVID-19 vaccine may induce various clinical subtypes of GBS, including a rare variant with sensory ataxia and dysgeusia. The Japanese Society of Internal Medicine 2022-03-26 2022-06-01 /pmc/articles/PMC9259306/ /pubmed/35342134 http://dx.doi.org/10.2169/internalmedicine.8967-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Ogata, Shunsuke Ishii, Yoshito Asano, Keiichiro Kobayashi, Erena Kubota, Shun Takahashi, Keita Miyaji, Yosuke Higashiyama, Yuichi Joki, Hideto Doi, Hiroshi Koga, Michiaki Takeuchi, Hideyuki Tanaka, Fumiaki Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination |
| title | Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination |
| title_full | Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination |
| title_fullStr | Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination |
| title_full_unstemmed | Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination |
| title_short | Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination |
| title_sort | sensory ataxic guillain-barré syndrome with dysgeusia after mrna covid-19 vaccination |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259306/ https://www.ncbi.nlm.nih.gov/pubmed/35342134 http://dx.doi.org/10.2169/internalmedicine.8967-21 |
| work_keys_str_mv | AT ogatashunsuke sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT ishiiyoshito sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT asanokeiichiro sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT kobayashierena sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT kubotashun sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT takahashikeita sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT miyajiyosuke sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT higashiyamayuichi sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT jokihideto sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT doihiroshi sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT kogamichiaki sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT takeuchihideyuki sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination AT tanakafumiaki sensoryataxicguillainbarresyndromewithdysgeusiaaftermrnacovid19vaccination |